Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Landmark Clinical Study Validates Patch-Based Onera Home-Polysomnography System in One of the Largest Sleep Diagnostic Trials of the Decade

Contributed by: Business Wire

Logo

Business Wire logo

Images

A woman is conducting a sleep test (polysomnography) using the patch-based Onera STS hPSG system. (Photo: Business Wire)
A woman is conducting a sleep test (polysomnography) using the patch-based Onera STS hPSG system. (Photo: Business Wire)
Business Wire embedded0

Tags

Research
Mobile/Wireless
Technology
Medical Devices
Clinical Trials
Biotechnology
Hardware
General Health
Health
Science
sleep diagnostic trial

More Like This

Patient sleeps with the patient-applied Onera home Polysomnography (Onera hPSG) solution.

New Clinical Study Publication Validates Respiratory Outcomes for the Onera Home-polysomnography System

Onera Sleep Test System (Onera STS): The innovative sensors of the patch-based Onera STS capture all signals required for a Polysomnography (PSG). (Photo: Business Wire)

Onera Presents New Clinical Data featuring the Innovative Onera STS at SLEEP 2024

A female patient is sleeping while undergoing a sleep study with Onera Health's home Polysomnography solution.

New Clinical Data Highlights Onera Health’s Patch-Based Home Polysomnography Solution at SLEEP 2025

Ruben de Francisco, Founder and CEO of Onera Health. (Photo: Business Wire)

Onera raises over €30M in Series C funding

Maria Sainz is the newly appointed Chair of the Board of Directors at Onera Health. (Photo: Business Wire)

Onera Health Appoints Maria Sainz as Chair of the Board

Business Wire logo

Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea

Business Wire logo

LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

Business Wire logo

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us